Manufacturer: GlaxoSmithKline, Philadelphia, PA Indication: A combination of topotecan and cisplatin is now available for the treatment of advanced (stage 4B) recurrent or persistent carcinomas of the cervix that are not amenable to curative treatment with surgery or radiation.
Manufacturer: Genentech, Inc., South San Francisco, CA Indication: The combination of bevacizumab and 5-fluo-rouracil (5-FU) is a first-line or second-line treatment for patients with metastatic colon or rectal cancer. Drug Class: Bevacizumab is a therapeutic antibody that is believed to work by targeting and inhibiting the function of a natural protein, vascular endothelial growth factor […]
Dasatinib Tablets (Sprycel) Manufacturer: Bristol-Myers Squibb Company, Princeton, NJ Indication: Dasatinib is indicated for the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast-phase chronic myeloid leukemia (CML) with resistance or intolerance to prior therapy, including imatinib mesylate (Gleevec, Novartis). The effectiveness of dasatinib is based on hematological and cytogenetic response rates. There […]